Cargando…
Changes in Glutathione Content in Liver Diseases: An Update
Glutathione (GSH), a tripeptide particularly concentrated in the liver, is the most important thiol reducing agent involved in the modulation of redox processes. It has also been demonstrated that GSH cannot be considered only as a mere free radical scavenger but that it takes part in the network go...
Autores principales: | Vairetti, Mariapia, Di Pasqua, Laura Giuseppina, Cagna, Marta, Richelmi, Plinio, Ferrigno, Andrea, Berardo, Clarissa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997318/ https://www.ncbi.nlm.nih.gov/pubmed/33670839 http://dx.doi.org/10.3390/antiox10030364 |
Ejemplares similares
-
Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research
por: Berardo, Clarissa, et al.
Publicado: (2020) -
The selective blockade of metabotropic glutamate receptor-5 attenuates fat accumulation in an in vitro model of benign steatosis
por: Ferrigno, Andrea, et al.
Publicado: (2020) -
Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update
por: Di Pasqua, Laura Giuseppina, et al.
Publicado: (2022) -
Isolation of rat hepatocytes for pharmacological studies on metabotropic glutamate receptor (mGluR) subtype 5: a comparison between collagenase I versus collagenase IV
por: Berardo, Clarissa, et al.
Publicado: (2020) -
Oxygen tension-independent protection against hypoxic cell killing in rat liver by low sodium
por: Ferrigno, Andrea, et al.
Publicado: (2017)